URW released Q1 results which are a strong improvement on the PCP. However, the results have not recovered to 2019 levels, though I was never expecting URW to do so at this stage. URW's FY22 AREPS guidance of EUR 8.20-8.40 (or around 61c per CDI) was maintained.
Footfall is still down compared to 2019, however, tenant sales are improving at a faster rate. Indicating shoppers are spending more per a visit than in 2019 (inflation could be a factor here?). The table below shows footfall and tenant sales by geography with the PCP in 2019, as a percentage of 2019 results. The US is clearly leading the recovery as expected. Sales in the US already above pre-COVID levels. March results show the trend is upwards. The entertainment category sales are still struggling down 21.6 in US and 25.8 in Europe.
Results align with my expectations of an eventual recovery. While I don't think URW will be as valuable as it was pre-COVID, URW is still significantly undervalued at well below book/replacement value.